rs2285644

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000342.4(SLC4A1):​c.2561C>T​(p.Pro854Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00278 in 1,614,206 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0035 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 76 hom. )

Consequence

SLC4A1
NM_000342.4 missense

Scores

5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:9

Conservation

PhyloP100: -0.155

Publications

34 publications found
Variant links:
Genes affected
SLC4A1 (HGNC:11027): (solute carrier family 4 member 1 (Diego blood group)) The protein encoded by this gene is part of the anion exchanger (AE) family and is expressed in the erythrocyte plasma membrane, where it functions as a chloride/bicarbonate exchanger involved in carbon dioxide transport from tissues to lungs. The protein comprises two domains that are structurally and functionally distinct. The N-terminal 40kDa domain is located in the cytoplasm and acts as an attachment site for the red cell skeleton by binding ankyrin. The glycosylated C-terminal membrane-associated domain contains 12-14 membrane spanning segments and carries out the stilbene disulphonate-sensitive exchange transport of anions. The cytoplasmic tail at the extreme C-terminus of the membrane domain binds carbonic anhydrase II. The encoded protein associates with the red cell membrane protein glycophorin A and this association promotes the correct folding and translocation of the exchanger. This protein is predominantly dimeric but forms tetramers in the presence of ankyrin. Many mutations in this gene are known in man, and these mutations can lead to two types of disease: destabilization of red cell membrane leading to hereditary spherocytosis, and defective kidney acid secretion leading to distal renal tubular acidosis. Other mutations that do not give rise to disease result in novel blood group antigens, which form the Diego blood group system. Southeast Asian ovalocytosis (SAO, Melanesian ovalocytosis) results from the heterozygous presence of a deletion in the encoded protein and is common in areas where Plasmodium falciparum malaria is endemic. One null mutation in this gene is known, resulting in very severe anemia and nephrocalcinosis. [provided by RefSeq, Jul 2008]
SLC4A1 Gene-Disease associations (from GenCC):
  • autosomal dominant distal renal tubular acidosis
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary spherocytosis type 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • renal tubular acidosis, distal, 4, with hemolytic anemia
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • southeast Asian ovalocytosis
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • dehydrated hereditary stomatocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cryohydrocytosis
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.024487436).
BP6
Variant 17-44251253-G-A is Benign according to our data. Variant chr17-44251253-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 17768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00346 (527/152336) while in subpopulation EAS AF = 0.0247 (128/5186). AF 95% confidence interval is 0.0212. There are 4 homozygotes in GnomAd4. There are 269 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC4A1NM_000342.4 linkc.2561C>T p.Pro854Leu missense_variant Exon 19 of 20 ENST00000262418.12 NP_000333.1
SLC4A1XM_011525129.3 linkc.2471C>T p.Pro824Leu missense_variant Exon 18 of 19 XP_011523431.1
SLC4A1XM_005257593.6 linkc.2366C>T p.Pro789Leu missense_variant Exon 17 of 18 XP_005257650.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC4A1ENST00000262418.12 linkc.2561C>T p.Pro854Leu missense_variant Exon 19 of 20 1 NM_000342.4 ENSP00000262418.6
SLC4A1ENST00000399246.3 linkc.1463C>T p.Pro488Leu missense_variant Exon 14 of 15 5 ENSP00000382190.3

Frequencies

GnomAD3 genomes
AF:
0.00346
AC:
527
AN:
152220
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000917
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0200
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0246
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000367
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00830
AC:
2086
AN:
251180
AF XY:
0.00655
show subpopulations
Gnomad AFR exome
AF:
0.000555
Gnomad AMR exome
AF:
0.0415
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0282
Gnomad FIN exome
AF:
0.000833
Gnomad NFE exome
AF:
0.000317
Gnomad OTH exome
AF:
0.00473
GnomAD4 exome
AF:
0.00271
AC:
3963
AN:
1461870
Hom.:
76
Cov.:
33
AF XY:
0.00251
AC XY:
1828
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.000418
AC:
14
AN:
33480
American (AMR)
AF:
0.0386
AC:
1728
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0414
AC:
1643
AN:
39700
South Asian (SAS)
AF:
0.00161
AC:
139
AN:
86258
European-Finnish (FIN)
AF:
0.000805
AC:
43
AN:
53410
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.000223
AC:
248
AN:
1112010
Other (OTH)
AF:
0.00233
AC:
141
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
309
619
928
1238
1547
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00346
AC:
527
AN:
152336
Hom.:
4
Cov.:
32
AF XY:
0.00361
AC XY:
269
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000914
AC:
38
AN:
41580
American (AMR)
AF:
0.0199
AC:
305
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0247
AC:
128
AN:
5186
South Asian (SAS)
AF:
0.00269
AC:
13
AN:
4832
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000368
AC:
25
AN:
68026
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
31
63
94
126
157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00193
Hom.:
12
Bravo
AF:
0.00605
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.00710
AC:
862
Asia WGS
AF:
0.0130
AC:
46
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Oct 14, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 13, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20825599, 21637597, 17137217, 24724911, 8206915, 19727826) -

Hereditary spherocytosis type 4 Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

DIEGO BLOOD GROUP ANTIGEN Pathogenic:1
Jun 10, 1994
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Autosomal dominant distal renal tubular acidosis Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hemolytic anemia Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.64
D;T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.14
N
LIST_S2
Uncertain
0.90
D;D
MetaRNN
Benign
0.024
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Uncertain
2.7
M;.
PhyloP100
-0.15
PrimateAI
Benign
0.24
T
PROVEAN
Uncertain
-2.9
D;.
REVEL
Benign
0.21
Sift
Benign
0.040
D;.
Sift4G
Benign
0.073
T;T
Polyphen
0.79
P;.
Vest4
0.28
MVP
0.31
MPC
0.48
ClinPred
0.065
T
GERP RS
-1.5
Varity_R
0.085
gMVP
0.51
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2285644; hg19: chr17-42328621; COSMIC: COSV52258217; COSMIC: COSV52258217; API